Register information Patent

DE file number : 60 2016 078 490.4 (Status: not pending/lapsed, Query started: June 19, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTNot pending/lapsed
21DE file number DAKZ60 2016 078 490.4
96EP file numberEAKZ20 15 6766.6
97EP publication numberEPN3682915
54Designation/titleTIVORRICHTUNG UND VERFAHREN ZUR AUSGABE ORALER TRANSMUKOSALER DARREICHUNGSFORMEN
51IPC main classICM
(ICMV)		 A61M 1/02 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61M 1/14 (2006.01), A61M 1/16 (2006.01), A61M 1/18 (2006.01), A61M 5/307 (2006.01), A61M 5/315 (2006.01), A61J 7/00 (2006.01)
22DE application dateDATOct 28, 2016
96EP application dateEATOct 28, 2016
43Date of first publicationOTJul 22, 2020
Date of publication of grantPETMar 22, 2023
71/73Applicant/ownerINHVertical Pharmaceuticals, LLC, Alpharetta, GA, US
72InventorINDOMINGO, Casidy, San Mateo, CA 94401, US; CHIU, Edmond, San Francisco, CA 94122, US; BLACKWOOD, Bradley, San Jose, CA 95122, US
Address for service Marks & Clerk LLP, 1017 Luxembourg, LU
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562248837 P
Oct 30, 2015
Patent division in charge 41
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003682915A1
Searchable text: EP000003682915A1
Original document: EP000003682915B1
Searchable text: EP000003682915B1
43Date of first publicationEVTJul 22, 2020
Date of the first transfer into DPMAregisterEREGTJul 22, 2020
Date of the (most recent) update in DPMAregisterREGTJun 15, 2025
(Show all update days)(Hide all update days)
  • Jun 15, 2025
    • Status: changed
    • Due date: deleted
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2023: new
    • Procedures: Administrative procedure, Application deemed withdrawn due to non-payment of annual fee, 01.05.2025: new
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2023: deleted
  • Nov 12, 2024
    • St.36: changed (technical change)
  • Jun 20, 2024; Feb 22, 2024; Feb 8, 2024; Jan 11, 2024; Nov 3, 2023; Jun 2, 2023; Mar 30, 2023; Mar 7, 2023; Mar 2, 2023
    • Historical data not available for this/these date(s)
  • Jul 22, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jul 22, 2020  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Sep 3, 2020 Sep 3, 2020 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 22, 2023  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Apr 13, 2023 Apr 13, 2023 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jan 2, 2024 Mar 14, 2024 Details anzeigen
6 New applicant/owner details New applicant/owner details Jan 10, 2024 Feb 15, 2024 Details anzeigen
7 Administrative procedure Application is deemed to be withdrawn due to non-payment of annual fee/ IP right has lapsed due to non-payment of annual fee May 1, 2025  Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJul 22, 2020
Date of update of the procedureREGTJul 22, 2020
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTSep 3, 2020
Issue numberHN36
YearPJ2020
Publication dateVTSep 3, 2020
Type of publicationPARTBibliographic data
Date of update of the procedureREGTJul 22, 2020
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 22, 2023
Date of update of the procedureREGTJun 15, 2025
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 13, 2023
Issue numberHN15
YearPJ2023
Publication dateVTApr 13, 2023
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTMar 30, 2023
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJan 2, 2024
Issue numberHN11
YearPJ2024
Publication dateVTMar 14, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTFeb 22, 2024
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 10, 2024
Issue numberHN7
YearPJ2024
Publication dateVTFeb 15, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHVertical Pharmaceuticals, LLC, Alpharetta, GA, US
71/73Previous applicant/ownerINHFAcelRx Pharmaceuticals, Inc., 94063 Redwood City, Calif., US
Date of update of the procedureREGTFeb 8, 2024
View procedures Administrative procedure (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTAdministrative procedure
Legal/procedural statusVSTApplication is deemed to be withdrawn due to non-payment of annual fee/ IP right has lapsed due to non-payment of annual fee
Date of legal/procedural statusVSTTMay 1, 2025
Date of update of the procedureREGTJun 15, 2025